Aimei Health Technology Co., Ltd (AFJK) Stock
Financial Services · Shell Companies · US
$54.03
+30.57%
Last updated Jun 18, 2026 23:55 UTC
AFJK Key Statistics
Market Cap$330.76M
P/E (TTM)270.15
P/S (TTM)—
P/B (TTM)5.14
Revenue (TTM)$0.00
EPS (TTM)$0.20
Dividend Yield—
ROE (TTM)2.85%
Net Margin0.00%
Gross Margin0.00%
52W High$85.00
52W Low$23.45
Analyst View—
Price Target—
Employees2
Volume28,253
About Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
CEO: Junheng Xie. Company website
See AFJK live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open AFJK in Terminal See plans